Li Y, Rong Z, Li Z, Cui H, Li J, Xu XW (2023)
Structural insights into catalytical capability for CPT11 hydrolysis and substrate specificity of a novel marine microbial carboxylesterase, E93
Front Microbiol 13: 1081094

Sanghani SP, Quinney SK, Fredenburg TB, Davis WI, Murry DJ, Bosron WF (2004)
Hydrolysis of irinotecan and its oxidative metabolites, 7-ethyl-10-[4-N-(5-aminopentanoic acid)-1-piperidino] carbonyloxycamptothecin and 7-ethyl-10-[4-(1-piperidino)-1-amino]-carbonyloxycamptothecin, by human carboxylesterases CES1A1, CES2, and a newly expressed carboxylesterase isoenzyme, CES3
Drug Metabolism & Disposition: The Biological Fate of Chemicals 32: 505

Ma MK, McLeod HL (2003)
Lessons learned from the irinotecan metabolic pathway
Curr Med Chem 10: 41

Sai K, Kaniwa N, Ozawa S, Sawada JI (2001)
A new metabolite of irinotecan in which formation is mediated by human hepatic cytochrome P-450 3A4
Drug Metabolism & Disposition: The Biological Fate of Chemicals 29: 1505

Santos A, Zanetta S, Cresteil T, Deroussent A, Pein F, Raymond E, Vernillet L, Risse ML, Boige V, Gouyette A, Vassal G (2000)
Metabolism of irinotecan (CPT-11) by CYP3A4 and CYP3A5 in humans
Clin Cancer Research 6: 2012